US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 8.950
  • -0.080-0.89%
Close Dec 23 16:00 ET
  • 8.950
  • 0.0000.00%
Post 20:01 ET
1.28BMarket Cap-59.67P/E (TTM)

About Aurinia Pharmaceuticals Company

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Company Profile

SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees300
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter S. Greenleaf
  • President, Chief Executive Officer and Director
  • 10.57M
  • Joseph M. Miller
  • Chief Financial Officer and Principal Accounting Officer
  • 3.98M
  • Stephen P. Robertson
  • Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
  • 3.60M
  • Matthew Donley
  • Executive Vice President, Operations and Strategy
  • 4.56M
  • Craig A. Johnson
  • Director
  • --
  • Kevin C. Tang
  • Director
  • --
  • Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
  • Independent Director
  • 359.41K
  • Jeffrey Allen Bailey
  • Independent Director
  • 361.51K
  • Jill D. Leversage
  • Independent Director
  • 267.28K
  • Dr. David R.W. Jayne, F.R.C.P.,M.D.
  • Independent Director
  • 249.92K
Heat List
US
Overall
Symbol
Price
% Chg

No Data